Omicron News and Research

RSS

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

In a recent study posted to the medRxiv* pre-print server, researchers evaluated the immunogenicity of booster doses of alum-adjuvanted SCB-2019 vaccine candidate's three formulations.

6 Jun 2022

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

A recent phase 1/2 study under review at the Nature Portfolio journal and posted to the Research Square* preprint server demonstrated that a peptide-centered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) T-cell activator, CoVac-1, was efficient in B-cell deficient people.

6 Jun 2022

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

A new study found that despite a lower COVID-19 vaccine efficacy against reinfection with the Omicron variant, these vaccines demonstrate a marked efficacy against reinfection with SARS-CoV-2 Alpha and Delta variants, as well as the Omicron variant.

3 Jun 2022

A system for detecting emerging SARS-CoV-2 variants

An article published in the journal Nature Medicine examines the unpredictable evolution of the ongoing COVID-19 pandemic.

2 Jun 2022

Vaccine-induced immunity against severe COVID-19 remains high for about six months

Protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19 remains high for about six months, according to a recent study by Penn State College of Medicine scientists.

2 Jun 2022

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge

Researchers evaluated how effective nirmatrelvir is in preventing COVID-19-associated death and hospitalization in high-risk patients.

2 Jun 2022

SARS-CoV-2 variant emergence patterns across Alaska

A new study preprint server assesses the pattern of SARS-CoV-2 variant emergence across Alaska.

1 Jun 2022

Inverse relationship identified between SARS-CoV-2 and influenza infections

A new study identifies the potential correlations that exist between SARS-CoV-2 and influenza infections.

1 Jun 2022

COVID-19 infections during the Omicron wave in unvaccinated US adults

Researchers assessed the incidence of SARS-CoV-2 infections during the prevalence of the SARS-CoV-2 Omicron variant.

1 Jun 2022

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Researchers hypothesized that the emergence of resistant SARS-CoV-2 variants can be anticipated by identifying possible escape mutations already present in the existing SARS-CoV-2 populations.

1 Jun 2022

‘Desperate situation’: States are housing high-needs foster kids in offices and hotels

Isela Perez entered the custody of Georgia's child welfare system at age 10. It happened after her father was deported and her mother left her and her brother alone in their home for two weeks, she said.

1 Jun 2022

SARS-CoV-2 infection during late pregnancy can lead to severe inflammatory responses in the placenta

SARS-CoV-2 infections of women in late pregnancy frequently spread to their placentas and led to inflammation, according to a study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.

31 May 2022

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

Researchers compared the performance of a highly multiplexed mass spectrometry-based commercial assay to identify SARS-CoV-2 variants.

31 May 2022

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

Researchers reported the vaccine effectiveness and duration of immunity against SARS-CoV-2 Omicron.

31 May 2022

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

A recent article assessed the potency of tixagevimab/cilgavimab in averting SARS-CoV-2 infection in vaccinated immunocompromised people.

31 May 2022

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

A recent study evaluated the protection conferred by mRNA vaccines and prior infection against the SARS-CoV-2 Omicron variant.

31 May 2022

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

Researchers assessed the safety and immunogenicity of SARS-CoV-2 booster vaccines.

31 May 2022

Omicron News and Research

Safety and efficacy of SCB-2019 COVID vaccine candidate as a ChAdOx1-S booster

Trial of peptide-centered SARS-CoV-2 T-cell activator in B-cell deficient individuals

Vaccine effectiveness against SARS-CoV-2 reinfection during periods with different dominant SARS-CoV-2 variants

A system for detecting emerging SARS-CoV-2 variants

Vaccine-induced immunity against severe COVID-19 remains high for about six months

The effectiveness of nirmatrelvir therapy for preventing mortality and hospitalizations due to COVID-19 in high-risk patients during the Omicron surge

SARS-CoV-2 variant emergence patterns across Alaska

Inverse relationship identified between SARS-CoV-2 and influenza infections

COVID-19 infections during the Omicron wave in unvaccinated US adults

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

‘Desperate situation’: States are housing high-needs foster kids in offices and hotels

SARS-CoV-2 infection during late pregnancy can lead to severe inflammatory responses in the placenta

Robust and highly multiplexed assay for identification of SARS-CoV-2 variants

Evidence on COVID-19 vaccine effectiveness and duration of protection against Omicron

The effectiveness of tixagevimab/cilgavimab for prevention of SARS-CoV-2 infection and severe disease among immunocompromised patients

Study evaluates protection conferred by prior infection and vaccination against the SARS-CoV-2 Omicron variant within the California state prison system

The immunogenicity and safety of the adjuvanted recombinant protein vaccine Sanofi/GSK-D614 or -B.1.351 administered as a heterologous booster dose

HIV research enables knowledge transfer for improved COVID-19 response

SARS-CoV-2 evolutionary trends provide insights into its adaptive process to human hosts

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News